Altitude Case Study

The Scientific Breakthrough Came First–Then the Brand that Would Share it With the World

THE CHALLENGE

In 2013, researchers at the University of Helsinki developed the first non-invasive diagnostic test for Lynch Syndrome before cancer develops–a medical breakthrough that could save millions of lives.

To commercialize the test, they founded the company “LSCancerDiag” and have spent the past decade undergoing research, validation, and regulatory approval in Europe. On the cusp of entering the American market, the science-led team knew it needed a new brand that would appeal to funders and healthcare providers alike.

THE SOLUTION

Altitude started the engagement with thorough research and discovery, not just to deeply understand the science. We needed to learn how to craft messaging that would educate the patients, doctors, and healthcare systems who don’t yet know the test’s life-saving potential. Hundreds of names on a whiteboard morphed into Lynsight–a transformational identity for a transformational technology. From messaging like “Finding a path forward for families with hereditary cancer” to a new logo, custom-built website, and thought-leadership content, Altitude has helped launch a new era for the company–and a new era for the prevention of diseases caused by Lynch Syndrome.

As we introduce our diagnostic solutions to the US market, having an appealing and consistent brand strategy and reliable marketing execution is critical. The partnership with Altitude allows us to step up our game.

Philippe Arnez, Chief Business Officer Lynsight

Hedge Trackers

Daelight

Ready to work with the B2B marketing experts?

We help leading business-to-business brands hit their marketing and sales goals. Get in touch to learn what Altitude Marketing can do for your B2B company.